Cortisone in coccidioidomycosis.

Area of Science:

• Infectious Diseases
• Pulmonology
• Immunology

Background:

• Primary pulmonary coccidioidomycosis presents with allergic manifestations.
• The use of corticosteroids in infectious diseases requires careful consideration of potential side effects.
• Coccidioidomycosis is a fungal infection endemic to specific regions.

Purpose of the Study:

• To evaluate the effect of low-dose, short-term oral cortisone on allergic symptoms in primary pulmonary coccidioidomycosis.
• To assess the impact of cortisone administration on coccidioidin skin test reactions and serologic patterns.
• To investigate the potential for cortisone to cause dissemination of coccidioidomycosis.

Main Methods:

• Oral cortisone was administered in low dosages for brief periods to 19 patients with primary pulmonary coccidioidomycosis.
• Patients' allergic manifestations were monitored.
• Coccidioidin skin test reactions and serologic patterns were assessed.
• A survey was conducted to identify any reported cases of disseminated coccidioidomycosis following cortisone administration.

Main Results:

• Cortisone promptly suppressed allergic manifestations in all 19 cases.
• No interference with coccidioidin skin test reactions or serologic patterns was observed.
• No instances of disease dissemination following cortisone or corticotropin administration were reported in the study or through a survey.

Conclusions:

• Low-dose, short-term oral cortisone appears to be effective in managing allergic symptoms of primary pulmonary coccidioidomycosis.
• Cortisone administration did not negatively affect diagnostic markers or lead to disease dissemination in this cohort.
• Further research is needed to fully understand the role of corticosteroids in coccidioidomycosis management.